MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

    AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)

    Objective: To describe the clinical characteristics of tremor in multiple sclerosis (MS) patients in Nepal and assess its functional impact on daily living. To describe…
  • 2026 International Congress

    Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

    E. Abed (Cairo, Egypt)

    Objective: To compare diet quality and nutrient intake between PD patients and controls and examine associations with PD clinical features. Background: Parkinson’s disease (PD) is…
  • 2026 International Congress

    Homozygous PRRT2 Frameshift Mutation Presenting with Infantile Onset Seizures and Childhood Episodic Ataxia

    P. Bhatele, P. Kukkle (Manipal, India)

    Objective: To report a rare presentation of a homozygous PRRT2 frameshift mutation manifesting as infantile-onset seizures followed by childhood episodic gait imbalance. Background: PRRT2 mutations…
  • 2026 International Congress

    Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation

    A. Szymanska, E. Franzén, L. Dahlin, S. Grigoriou, B. Lindholm (Malmö, Sweden)

    Objective: To describe grip strength and upper limb (UL) distress in de novo PD, and to explore associations with motor symptoms. Background: Grip strength is…
  • 2026 International Congress

    Use of Mucuna Pruriens (M. Pruriens) in People with Parkinson’s Disease (PwPD)

    M. Bacigalupe, M. López, D. Merino (La Plata, Argentina)

    Objective: To characterize M. pruriens use among local (primarily Argentinian) PwPD. Background: M. pruriens is a leguminous plant used in Ayurvedic medicine to treat Parkinsonism…
  • 2026 International Congress

    Can a slogan poster featuring the patient’s primary physician help improve gait and prevent falls at home in patients with Parkinson’s disease?

    Y. Okuma (Izunokuni, Japan)

    Objective: To present cases with Parkinson’s disease (PD) suggesting that a slogan poster aimed at improving gait and preventing falls may be effective. Background: Patients…
  • 2026 International Congress

    An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

    Objective: To present the protocol of the Artificial Intelligence-based Parkinson’s Risk Assessment (AI-PRA) study which aims to validate a novel personalised PD risk prediction model…
  • 2026 International Congress

    Irisin as a Molecular Mediator of Exercise Induced Neuroprotection and Disease Modification in Parkinson’s Disease

    NIK. Choudhary (Jodhpur, India)

    Objective: To integrate mechanistic evidence delineating irisin mediated molecular pathways relevant to Parkinson’s disease (PD) pathogenesis and neuroprotection, focusing on α-syn clearance, autophagy–lysosomal function, mitochondrial…
  • 2026 International Congress

    Urate Levels and Risk of Parkinson’s Disease:A Two-Sample Mendelian Randomization Study

    P. Tang, Y. Liu (Xi'an, China)

    Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…
  • 2026 International Congress

    Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor

    A. Aralbayeva, Z. Akhmetzhanova, A. Baidarbekova (Astana, Kazakhstan)

    Objective: To synthesize current experimental and translational evidence supporting the hypothesis that micro- and nanoplastics (MNPs) may contribute to Parkinson’s disease (PD) pathogenesis through neuroinflammatory…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley